Announcements Trials

Browse Landscape

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 13 Lymphoma, Follicular 7 Lymphoma, B-Cell, Marginal Zone 5 Waldenstrom Macroglobulinemia 4 Lymphoma, Non-Hodgkin 4 Lymphoma, Mantle-Cell 3 Lymphoma, B-Cell 2 Leukemia, Myeloid, Acute 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Multiple Myeloma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia, B-Cell 1 Leukemia 1 Hodgkin Disease 1

Interventions

ofatumumab 10 Rituximab 6 ibrutinib 5 Cyclophosphamide 5 fludarabine phosphate 4 Bendamustine Hydrochloride 4 fludarabine 3 Lenalidomide 3 Alemtuzumab 3 spebrutinib 2 navitoclax 2 acalabrutinib 2 KW-2478 2 venetoclax 1 tirabrutinib 1 obinutuzumab 1 idelalisib 1 dinaciclib 1 Tablets 1 Stem Cell Transplantation 1 Rabeprazole 1 Pentostatin 1 Metronidazole 1 Methylprednisolone 1 Magnetic Resonance Imaging 1 MLN 8237 1 Leukapheresis 1 Lansoprazole 1 Itraconazole 1 Immunotherapy, Adoptive 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Leukemia, B-Cell × idelalisib × Clear all

NCT03582098 2019-04-12

RETRO-idel

Gilead Sciences

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡